Form 4: Eli Lilly Director Acquires Shares Under Deferral Plan

Director Juan R. Luciano acquired 18.133 shares of Eli Lilly & Co common stock under the company's Directors' Deferral Plan.

Summary

• On April 21, 2025, Juan R. Luciano, a director of Eli Lilly & Co, acquired 18.133 shares of common stock.
• The acquisition was made under the Lilly Directors' Deferral Plan at a price of $818.02 per share.
• These shares are deferred in lieu of cash compensation and will be settled in shares of common stock following Luciano's separation from service.
• Following the transaction, Luciano beneficially owns 16,294.186 shares of Eli Lilly & Co common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a routine transaction (share acquisition by a director under a deferral plan) with no explicit positive or negative implications.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.
• The Directors' Deferral Plan allows directors to align their interests with those of long-term shareholders.

Future Outlook

The acquired shares will be settled in shares of common stock following the reporting person's separation from service.

Industry Context

Director share acquisitions are common in publicly traded companies and are often seen as a way to align the interests of management with those of shareholders. These transactions are routinely disclosed through SEC filings like Form 4.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it indicates confidence from a company director.

Key Dates

Keywords

Eli Lilly, Director, Share Acquisition, Deferral Plan, Form 4, Luciano, LLY, Beneficial Ownership